靶点- |
作用机制- |
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期2016-01-05 |
靶点- |
作用机制- |
在研机构- |
|
在研适应症- |
|
最高研发阶段终止 |
首次获批国家/地区- |
首次获批日期- |
A Prospective, Multi-Center, Randomized, Controlled Clinical Trial Designed to Evaluate the Safety and Preliminary Efficacy of V404 PDS in Chronic Noninfectious Uveitis
This study is intended to evaluate the safety of V404 PDS in patients with chronic non-infectious uveitis. Secondarily, the study will evaluate whether V404 PDS can provide clinically measurable benefit over an extended period of time in patients with chronic non-infectious uveitis.
Safety and Preliminary Efficacy Study of PDS-1.0 in Patients With Neovascular AMD
This study will evaluate the safety and preliminary effectiveness of PDS 1.0 in patients with neovascular AMD.
Preliminary Safety and Efficacy of the PDS-1.0 in Patients With Neovascular Age Related Macular Degeneration (AMD)
This study will evaluate the preliminary safety and efficacy of PDS 1.0 in patients with neovascular AMD.
100 项与 ForSight VISION4, Inc. 相关的临床结果
0 项与 ForSight VISION4, Inc. 相关的专利(医药)
100 项与 ForSight VISION4, Inc. 相关的药物交易
100 项与 ForSight VISION4, Inc. 相关的转化医学